Copyright © 2012 Anat Elmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. I. Casetta, V. Govoni, and E. Granieri, “Oxidative stress, antioxidants and neurodegenerative diseases,” Current Pharmaceutical Design, vol. 11, no. 16, pp. 2033–2052, 2005. View at Publisher · View at Google Scholar · View at Scopus
2. B. Halliwell, “Oxidative stress and neurodegeneration: where are we now?” Journal of Neurochemistry, vol. 97, no. 6, pp. 1634–1658, 2006. View at Publisher · View at Google Scholar · View at Scopus
3. P. A. Hyslop, Z. Zhang, D. V. Pearson, and L. A. Phebus, “Measurement of striatal H₂O₂ by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H₂O₂in vitro,” Brain Research, vol. 671, no. 2, pp. 181–186, 1995. View at Publisher · View at Google Scholar · View at Scopus
4. H. Ischiropoulos and J. S. Beckman, “Oxidative stress and nitration in neurodegeneration: cause, effect, or association?” Journal of Clinical Investigation, vol. 111, no. 2, pp. 163–169, 2003. View at Publisher · View at Google Scholar · View at Scopus
5. L. Minghetti, “Role of inflammation in neurodegenerative diseases,” Current Opinion in Neurology, vol. 18, no. 3, pp. 315–321, 2005. View at Scopus
6. R. A. Floyd, “Antioxidants, oxidative stress, and degenerative neurological disorders,” Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 3, pp. 236–245, 1999. View at Scopus
7. P. S. Sastry, “Lipids of nervous tissue: composition and metabolism,” Progress in Lipid Research, vol. 24, no. 2, pp. 69–176, 1985. View at Scopus
8. B. Hallgren and P. Sourander, “The effect of age on the non-hem iron in the human brain,” Journal of Neurochemistry, vol. 3, no. 1, pp. 41–51, 1958. View at Publisher · View at Google Scholar
9. R. Schreck and A. Baeuerle, “A role for oxygen radicals as second messengers,” Trends in Cell Biology, vol. 1, no. 2-3, pp. 39–42, 1991. View at Scopus
10. R. Dringen, P. G. Pawlowski, and J. Hirrlinger, “Peroxide detoxification by brain cells,” Journal of Neuroscience Research, vol. 79, no. 1-2, pp. 157–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
11. G. P. Bienert, J. K. Schjoerring, and T. P. Jahn, “Membrane transport of hydrogen peroxide,” Biochimica et Biophysica Acta, vol. 1758, no. 8, pp. 994–1003, 2006. View at Publisher · View at Google Scholar · View at Scopus
12. D. Vaudry, T. F. Pamantung, M. Basille et al., “PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis,” European Journal of Neuroscience, vol. 15, no. 9, pp. 1451–1460, 2002. View at Publisher · View at Google Scholar · View at Scopus
13. A. Ferrero-Gutiérrez, A. Pérez-Gómez, A. Novelli, and M. T. Fernández-Sánchez, “Inhibition of protein phosphatases impairs the ability of astrocytes to detoxify hydrogen peroxide,” Free Radical Biology and Medicine, vol. 44, no. 10, pp. 1806–1816, 2008. View at Publisher · View at Google Scholar · View at Scopus
14. S. Y. Assaf and S. H. Chung, “Release of endogenous Zn²⁺ from brain tissue during activity,” Nature, vol. 308, no. 5961, pp. 734–736, 1984. View at Scopus
15. D. W. Choi and J. Y. Koh, “Zinc and brain injury,” Annual Review of Neuroscience, vol. 21, pp. 347–375, 1998. View at Publisher · View at Google Scholar · View at Scopus
16. A. Côté, M. Chiasson, M. R. Peralta III, K. Lafortune, L. Pellegrini, and K. Tóth, “Cell type-specific action of seizure-induced intracellular zinc accumulation in the rat hippocampus,” Journal of Physiology, vol. 566, no. 3, pp. 821–837, 2005. View at Publisher · View at Google Scholar · View at Scopus
17. H. Li, R. Swiercz, and E. W. Englander, “Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA,” Journal of Neurochemistry, vol. 110, no. 6, pp. 1774–1783, 2009. View at Publisher · View at Google Scholar · View at Scopus
18. Y. Li, C. J. Hough, S. W. Suh, J. M. Sarvey, and C. J. Frederickson, “Rapid translocation of Zn²⁺ from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation,” Journal of Neurophysiology, vol. 86, no. 5, pp. 2597–2604, 2001. View at Scopus
19. C. J. Frederickson, J. Y. Koh, and A. I. Bush, “The neurobiology of zinc in health and disease,” Nature Reviews Neuroscience, vol. 6, no. 6, pp. 449–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
20. J. Ryu, C. Shin, J. W. Choi et al., “Depletion of intracellular glutathione mediates zinc-induced cell death in rat primary astrocytes,” Experimental Brain Research, vol. 143, no. 2, pp. 257–263, 2002. View at Publisher · View at Google Scholar · View at Scopus
21. E. Y. Kim, J. Y. Koh, Y. H. Kim, S. Sohn, E. Joe, and B. J. Gwag, “Zn²⁺ entry produces oxidative neuronal necrosis in cortical cell cultures,” European Journal of Neuroscience, vol. 11, no. 1, pp. 327–334, 1999. View at Scopus
22. Y. H. Kim, E. Y. Kim, B. J. Gwag, S. Sohn, and J. Y. Koh, “Zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals,” Neuroscience, vol. 89, no. 1, pp. 175–182, 1999. View at Publisher · View at Google Scholar · View at Scopus
23. G. W. Kim, Y. Gasche, S. Grzeschik, J. C. Copin, C. M. Maier, and P. H. Chan, “Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption?” Journal of Neuroscience, vol. 23, no. 25, pp. 8733–8742, 2003. View at Scopus
24. G. M. Bishop, R. Dringen, and S. R. Robinson, “Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes,” Free Radical Biology and Medicine, vol. 42, no. 8, pp. 1222–1230, 2007. View at Publisher · View at Google Scholar · View at Scopus
25. N. C. Danbolt, “The high affinity uptake system for excitatory amino acids in the brain,” Progress in Neurobiology, vol. 44, no. 4, pp. 377–396, 1994. View at Publisher · View at Google Scholar · View at Scopus
26. G. Barreto, R. E. White, Y. Ouyang, L. Xu, and R. G. Giffard, “Astrocytes: targets for neuroprotection in stroke,” Central Nervous System Agents in Medicinal Chemistry, vol. 11, no. 2, pp. 164–173, 2011. View at Scopus
27. H. Song, C. F. Stevens, and F. H. Gage, “Astroglia induce neurogenesis from adult neural stem cells,” Nature, vol. 417, no. 6884, pp. 39–44, 2002. View at Publisher · View at Google Scholar · View at Scopus
28. E. M. Ullian, K. S. Christopherson, and B. A. Barres, “Role for glia in synaptogenesis,” Glia, vol. 47, no. 3, pp. 209–216, 2004. View at Publisher · View at Google Scholar · View at Scopus
29. K. Takuma, A. Baba, and T. Matsuda, “Astrocyte apoptosis: implications for neuroprotection,” Progress in Neurobiology, vol. 72, no. 2, pp. 111–127, 2004. View at Publisher · View at Google Scholar · View at Scopus
30. P. Åkerud, J. Alberch, S. Eketjäll, J. Wagner, and E. Arenas, “Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons,” Journal of Neurochemistry, vol. 73, no. 1, pp. 70–78, 1999. View at Publisher · View at Google Scholar · View at Scopus
31. R. E. Burke, M. Antonelli, and D. Sulzer, “Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture,” Journal of Neurochemistry, vol. 71, no. 2, pp. 517–525, 1998. View at Scopus
32. T. F. Oo, N. Kholodilov, and R. E. Burke, “Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo,” Journal of Neuroscience, vol. 23, no. 12, pp. 5141–5148, 2003. View at Scopus
33. M. J. Bourque and L. E. Trudeau, “GDNF enhances the synaptic efficacy of dopaminergic neurons in culture,” European Journal of Neuroscience, vol. 12, no. 9, pp. 3172–3180, 2000. View at Publisher · View at Google Scholar · View at Scopus
34. A. C. Yu, R. Y. Liu, Y. Zhang et al., “Glial cell line-derived neurotrophic factor protects astrocytes from staurosporine- and ischemia-induced apoptosis,” Journal of Neuroscience Research, vol. 85, no. 15, pp. 3457–3464, 2007. View at Publisher · View at Google Scholar · View at Scopus
35. S. J. Robb, L. D. Robb-Gaspers, R. C. Scaduto, A. P. Thomas, and J. R. Connor, “Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes,” Journal of Neuroscience Research, vol. 55, no. 6, pp. 674–686, 1999.
36. C. J. Feeney, M. V. Frantseva, P. L. Carlen et al., “Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices,” Brain Research, vol. 1198, pp. 1–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
37. M. Lu, L. F. Hu, G. Hu, and J. S. Bian, “Hydrogen sulfide protects astrocytes against H₂O₂-induced neural injury via enhancing glutamate uptake,” Free Radical Biology and Medicine, vol. 45, no. 12, pp. 1705–1713, 2008. View at Publisher · View at Google Scholar · View at Scopus
38. F. Bakkali, S. Averbeck, D. Averbeck, and M. Idaomar, “Biological effects of essential oils—a review,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 446–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
39. T. S. Anekonda and P. H. Reddy, “Can herbs provide a new generation of drugs for treating Alzheimer's disease?” Brain Research Reviews, vol. 50, no. 2, pp. 361–376, 2005. View at Publisher · View at Google Scholar · View at Scopus
40. V. Solfrizzi, F. Panza, and A. Capurso, “The role of diet in cognitive decline,” Journal of Neural Transmission, vol. 110, no. 1, pp. 95–110, 2003. View at Scopus
41. H. J. Wengreen, R. G. Munger, C. D. Corcoran et al., “Antioxidant intake and cognitive function of elderly men and women: the Cache County study,” Journal of Nutrition, Health and Aging, vol. 11, no. 3, pp. 230–237, 2007. View at Scopus
42. R. M. A. Mansour, A. A. Ahmed, F. R. Melek, and N. A. M. Saleh, “The flavonoids of Pulicaria incisa,” Fitoterapia, vol. 61, no. 2, pp. 186–187, 1990. View at Scopus
43. N. A. M. Saleh, “Global phytochemistry: the Egyptian experience,” Phytochemistry, vol. 63, no. 3, pp. 239–241, 2003. View at Publisher · View at Google Scholar · View at Scopus
44. M. M. Shabana, Y. W. Mirhom, A. A. Genenah, E. A. Aboutabl, and H. A. Amer, “Study into wild Egyptian plants of potential medicinal activity. Ninth communication: hypoglycaemic activity of some selected plants in normal fasting and alloxanised rats.,” Archiv fur Experimentelle Veterinarmedizin, vol. 44, no. 3, pp. 389–394, 1990. View at Scopus
45. W. Abd El-Gleel and M. Hassanien, “Antioxidant properties and lipid profile of Diplotaxis harra, Pulicaria incisa and Avicennia marina,” Acta Alimentaria, vol. 41, no. 2, pp. 143–151, 2012. View at Publisher · View at Google Scholar
46. M. M. A. Amer, M. F. Ramadan, and W. Abd El-Gleel, “Impact of pulicaria incisa, diplotaxis harra and avicennia marina as hypocholesterolemic agent,” Deutsche Lebensmittel-Rundschau, vol. 103, no. 7, pp. 320–327, 2007. View at Scopus
47. M. Stavri, K. T. Mathew, A. Gordon, S. D. Shnyder, R. A. Falconer, and S. Gibbons, “Guaianolide sesquiterpenes from Pulicaria crispa (Forssk.) oliv.,” Phytochemistry, vol. 69, no. 9, pp. 1915–1918, 2008. View at Publisher · View at Google Scholar
48. V. W. Bowry and R. Stocker, “Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein,” Journal of the American Chemical Society, vol. 115, no. 14, pp. 6029–6044, 1993. View at Scopus
49. E. Niki, M. Saito, Y. Yoshikawa, Y. Yamamoto, and Y. Kamiya, “Oxidation of lipids XII. Inhibition of oxidation of soybean phosphatidylcholine and methyl linoleate in aqueous dispersions by uric acid,” Bulletin of the Chemical Society of Japan, vol. 59, no. 2, pp. 471–477, 1986. View at Publisher · View at Google Scholar
50. M. J. Thomas, Q. Chen, C. Franklin, and L. L. Rudel, “A comparison of the kinetics of low-density lipoprotein oxidation initiated by copper or by azobis (2-amidinopropane),” Free Radical Biology and Medicine, vol. 23, no. 6, pp. 927–935, 1997. View at Publisher · View at Google Scholar · View at Scopus
51. H. Wang and J. A. Joseph, “Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader,” Free Radical Biology and Medicine, vol. 27, no. 5-6, pp. 612–616, 1999. View at Publisher · View at Google Scholar · View at Scopus
52. K. L. Wolfe and H. L. Rui, “Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements,” Journal of Agricultural and Food Chemistry, vol. 55, no. 22, pp. 8896–8907, 2007. View at Publisher · View at Google Scholar · View at Scopus
53. J. Alberch, E. Pérez-Navarro, and J. M. Canals, “Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease,” Brain Research Bulletin, vol. 57, no. 6, pp. 817–822, 2002. View at Publisher · View at Google Scholar · View at Scopus
54. E. A. Burton, J. C. Glorioso, and D. J. Fink, “Gene therapy progress and prospects: Parkinson's disease,” Gene Therapy, vol. 10, no. 20, pp. 1721–1727, 2003. View at Publisher · View at Google Scholar · View at Scopus
55. Y. Manabe, I. Nagano, A. Gazi et al., “Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis,” Neurological Research, vol. 25, no. 2, pp. 195–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
56. N. Altiok, M. Ersoz, V. Karpuz, and M. Koyuturk, “Ginkgo biloba extract regulates differentially the cell death induced by hydrogen peroxide and simvastatin,” NeuroToxicology, vol. 27, no. 2, pp. 158–163, 2006. View at Publisher · View at Google Scholar · View at Scopus
57. M. F. Ramadan, M. M. A. Amer, H. T. Mansour et al., “Bioactive lipids and antioxidant properties of wild Egyptian Pulicaria incise, Diplotaxis harra, and Avicennia marina,” Journal fur Verbraucherschutz und Lebensmittelsicherheit, vol. 4, no. 3, pp. 239–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
58. Z. P. Chen, J. B. Schell, C. T. Ho, and K. Y. Chen, “Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts,” Cancer Letters, vol. 129, no. 2, pp. 173–179, 1998. View at Publisher · View at Google Scholar · View at Scopus
59. J. P. Andrade and M. Assunção, “Protective effects of chronic green tea consumption on age-related neurodegeneration,” Current Pharmaceutical Design, vol. 18, no. 1, pp. 4–14, 2012. View at Publisher · View at Google Scholar
60. M. Sano, M. Suzuki, T. Miyase, K. Yoshino, and M. Maeda-Yamamoto, “Novel antiallergic catechin derivatives isolated from oolong tea,” Journal of Agricultural and Food Chemistry, vol. 47, no. 5, pp. 1906–1910, 1999. View at Publisher · View at Google Scholar · View at Scopus
61. L. K. Han, T. Takaku, J. Li, Y. Kimura, and H. Okuda, “Anti-obesity action of oolong tea,” International Journal of Obesity, vol. 23, no. 1, pp. 98–105, 1999. View at Scopus
62. D. L. McKay and J. B. Blumberg, “A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia),” Phytotherapy Research, vol. 21, no. 1, pp. 1–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
63. M. Iriti, S. Vitalini, G. Fico, and F. Faoro, “Neuroprotective herbs and foods from different traditional medicines and diets,” Molecules, vol. 15, no. 5, pp. 3517–3555, 2010. View at Publisher · View at Google Scholar · View at Scopus